GSK Threatens Access to Weight Loss Supplements

Washington, DC - GlaxoSmithKline, the second-largest pharmaceutical company in the world, has threatened your access to supplements by petitioning the FDA to classify weight loss claims for dietary supplements as ‘disease claims’.

Washington, DC - On April 17th, 2008, pharmaceutical giant GlaxoSmithKline (GSK) submitted a Citizen Petition calling for the U.S. Food and Drug Administration (FDA) to reclassify all weight loss support claims for dietary supplements as disease claims. Read the full petition here.

Read full story at Citizens For Health

Fid

Read the new book, The Evidence, However, Is Clear...The Seroxat Scandal

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING